Nasal vestibulitis: an under-recognized and under-treated side effect of cancer treatment?

Elizabeth J Cathcart-RakeDeanne SmithDavid ZahriehAminah JatoiPing YangCharles L Loprinzi

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2018)

Nasal vestibulitis is common among patients receiving taxane- and VEGF-related therapies; these symptoms are infrequently recorded or treated by healthcare providers.

Keyphrases

healthcare
chronic rhinosinusitis
endothelial cells
vascular endothelial growth factor
newly diagnosed
health information
social media